Remedee Labs Secures European Approval for Groundbreaking Fibromyalgia Wristband Therapy

European Approval:
Remedee Labs has received European approval for its fibromyalgia wristband therapy, making it the first CE marked medical device (class IIa) approved for treating fibromyalgia in Europe.

Non-Pharmaceutical Treatment:
The therapy uses millimeter-wave technology to stimulate the release of endorphins, providing relief from fibromyalgia symptoms without pharmaceuticals.

Clinical Validation:
The FIBREPIK study demonstrated significant improvements in quality of life for 6 out of 10 patients, with sustained benefits at 6 months. Patients reported improvements in pain, fatigue, anxiety, depression, and sleep quality.

Holistic Approach:
The therapy includes personalized coaching and a mobile application, offering a comprehensive care approach that aligns with current recommendations for fibromyalgia management.

Public Health Impact:
Fibromyalgia affects approximately 2% of the French population, with women making up 80-90% of patients. The approval of Remedee Labs' therapy offers a new, non-pharmaceutical treatment option for these patients.